Roth/MKM Starts CervoMed (CRVO) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
H.C. Wainwright Starts CervoMed (CRVO) at Buy
December 5, 2024 6:05 AM ESTH.C. Wainwright analyst Raghuram Selvaraju initiates coverage on CervoMed (NASDAQ: CRVO) with a Buy rating and a price target of $42.00.
For an analyst ratings summary and ratings history on CervoMed click here. For more ratings news on CervoMed click here.
Shares of CervoMed closed at $9.70 yesterday.
... More